Company · CIK 0001840574
Verve Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-25-165462 · 274.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-159005 · 151.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-141748 · 1.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-138470 · 149.4 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-25-070911 · 9.2 MBSEC(opens sec.gov)
- 8-KCurrent report0000950170-25-070905 · 330.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-079607 · 166.7 KBSEC(opens sec.gov)
- 10-KAnnual report0000950170-25-028376 · 14.4 MBSEC(opens sec.gov)
- 8-KCurrent report0000950170-25-028354 · 379.3 KBSEC(opens sec.gov)
- SC 13GVerve Therapeutics, Inc.0000921895-24-002770 · 285.4 KBSEC(opens sec.gov)
Insiders
- ADELMAN BURT ADirector
- Alphabet Inc.10% Owner
- ARCH Venture Fund X, L.P.10% Owner
- ARCH Venture Partners X, LLC10% Owner
- Ashe Andrew D.See Remarks
- Beam Therapeutics Inc.10% Owner
- Beaudoin MargaretVice President, Finance
- Bellinger AndrewChief Scientific Officer
- Biomatics Capital Partners, L.P.10% Owner
- Broad Institute, Inc.10% Owner
Tickers
No tickers on record.
Addresses
business
201 BROOKLINE AVENUE SUITE 601
BOSTON, MA, 02215
mailing
201 BROOKLINE AVENUE SUITE 601
BOSTON, MA, 02215
Same industry